Silence Therapeutics plc (SLN)
SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026
Other listed symbols of this issuer: SLNCF
as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗
In its 10-Q for the period ended Jun 30, 2026, Silence Therapeutics plc reported revenue of $0, net income of -$12.3M, and total assets of $106.4M. Every figure below is taken directly from Silence Therapeutics plc's SEC filings: each links to the source document on EDGAR.
Revenue trend
Revenue · FY2022–FY2025 · as reported
- FY2022 revenue
- $21.7M
- FY2025 revenue
- $559,000
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2025 | $559,000 | -$88.6M |
| FY2024 | $43.3M | -$45.3M |
| FY2023 | $31.6M | -$54.2M |
| FY2022 | $21.7M | -$50.3M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | Oct 19, 2026 | on EDGAR ↗ |
| 8-K | Aug 12, 2026 | on EDGAR ↗ |
| 8-K | Aug 10, 2026 | on EDGAR ↗ |
| 8-K | Aug 10, 2026 | on EDGAR ↗ |
| 10-Q | Aug 10, 2026 | on EDGAR ↗ |
| 8-K | Jun 23, 2026 | on EDGAR ↗ |
| 8-K | Jun 16, 2026 | on EDGAR ↗ |
| 8-K | Jun 11, 2026 | on EDGAR ↗ |
| 8-K | May 18, 2026 | on EDGAR ↗ |
| 8-K | May 7, 2026 | on EDGAR ↗ |
Balance Sheet
as of Jun 30, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Jun 30, 2026
Per Share & Cash Flow
10-Q (quarterly) · period ended Jun 30, 2026
| EPS (diluted) | $-0.09 | Earnings | source ↗ |
| EPS (basic) | $-0.09 | Earnings | source ↗ |
| Shares Outstanding | 141.7M | Entity | source ↗ |
| Cash from Operations | $1.5M | Net | source ↗ |
| Cash from Financing | $2,000 | Net | source ↗ |
| Cash from Investing | $64.9M | Net | source ↗ |
Insider activity
Form 4 open-market activity, last 180 days
No open-market Form 4 transactions filed in the last 180 days.
Restatement history
Point-in-timeNo material restatements detected across 103 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.
Deeper fundamentals
A free API key reaches SLN’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/SLN
MCP tool:
get_sec_fundamentals ticker=SLN - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/SLN/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=SLN as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/SLN/history
MCP tool:
get_fundamentals_history ticker=SLN - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/SLN
MCP tool:
get_financial_health ticker=SLN
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.